IOB - Delayed Quote USD

0R19.IL,0P00014L0M,692 (0R19.IL)

233.79

+2.75

+(1.19%)

At close: July 23 at 9:00:00 PM GMT+1

You can’t out-trade tariffs as stocks move in tandem

(Bloomberg) -- Traders have long known Donald Trump intended to use tariffs as a tool for economic policy. Citigroup Inc., a year ago, even offered up a handy framework for trading potential levies on China.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeDOGE Visits National Gallery of Art to Discuss Museum’s Legal StatusThe Racial Wealth Gap Is Not Just About MoneyWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesBackyard Micro-Flats Aim to Ease Sout

Bloomberg 2 days ago

ODFL

C

TGT
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial launch of Phasix™ ST Umbilical Hernia Patch, the first and only fully absorbable hernia patch on the market designed specifically for umbilical hernias.

PR Newswire 3 days ago

BDX
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (AI) based algorithms that can help clinicians proactively address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.

PR Newswire 5 days ago

BDX
BD to Announce Financial Results for its Second Quarter of Fiscal 2025

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to discuss the Company's financial results for its second quarter of fiscal year 2025, which ended on March 31, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made available sh

PR Newswire 22 days ago

BDX
BD Named One of America's Most Innovative Companies by Fortune

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture.

PR Newswire 26 days ago

BDX
BD Names Gregory J. Hayes to Board of Directors

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025.

PR Newswire 29 days ago

BDX
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD's efforts to achieve Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the use of GalaFLEX LITE™ Scaffold in decreasing capsular contracture (CC) recurrence during breast revision surgery.

PR Newswire last month

BDX
BD to Present at Investor Healthcare Conferences

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences:

PR Newswire 2 months ago

BDX
Becton Dickinson price target raised to $269 from $265 at BofA

BofA analyst Travis Steed raised the firm’s price target on Becton Dickinson (BDX) to $269 from $265 and keeps a Buy rating on the shares after the company reported fiscal Q1 EPS and announced its intent to separate the Biosciences and Diagnostic Solutions business. The “spin math” suggests a sum-of-the-parts value of $269 per share for the two pieces in total, but a potential sale “could drive even more value creation,” the analyst tells investors. Published first on TheFly – the ultimate sourc

TipRanks 2 months ago

BDX
Becton Dickinson First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Becton Dickinson ( NYSE:BDX ) First Quarter 2025 Results Key Financial Results Revenue: US$5.17b (up 9.8% from 1Q...

Simply Wall St. 2 months ago

BDX
Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and allow the company to invest more in innovation and margin growth.

The Wall Street Journal 2 months ago

BDX
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of BD to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business and enhance value creation for shareholders.

PR Newswire 2 months ago

BDX
Becton Dickinson (NYSE:BDX) Ticks All The Boxes When It Comes To Earnings Growth

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Simply Wall St. 2 months ago

BDX
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on March 31, 2025 to holders of record on March 10, 2025. The indicated annual dividend rate is $4.16 per share.

PR Newswire 2 months ago

BDX
DEI Pay Incentives Come Under Pressure After Two-Year Surge

Uber plans to change its compensation goals for diversity, equity and inclusion as big companies re-examine their policies.

The Wall Street Journal 2 months ago

TSN

PRU

COST
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.

PR Newswire 2 months ago

BDX
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care

Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Carilion is the first health system in the state and the Southeastern U.S. to provide its patients needle-free blood draws using the BD® PIVO™ Pro Needle-free Blood Collection Device. This initiative is part of Carilion's commitment to patient-centered care,

PR Newswire 3 months ago

BDX
Becton, Dickinson and Company's (NYSE:BDX) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Becton Dickinson's (NYSE:BDX) stock is up by 4.3% over the past month. As most would know, long-term fundamentals have...

Simply Wall St. 3 months ago

BDX
BD to Announce Financial Results for its First Quarter of Fiscal 2025

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, February 6, 2025 to discuss the Company's financial results for its first quarter of fiscal year 2025, which ended on December 31, 2024, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made avail

PR Newswire 3 months ago

BDX
New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the results of a new survey revealing that 74% of women in Canada have delayed a gynecology visit, with 83% wanting more accessible and less invasive cervical cancer testing options, including at-home self-collection for human papillomavirus (HPV) tests.

CNW Group 3 months ago

BDX

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

0R19.IL,0P00014L0M,692 (0R19.IL)

You can’t out-trade tariffs as stocks move in tandem

BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair

BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support

BD to Announce Financial Results for its Second Quarter of Fiscal 2025

BD Named One of America's Most Innovative Companies by Fortune

BD Names Gregory J. Hayes to Board of Directors

BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery

BD to Present at Investor Healthcare Conferences

Becton Dickinson price target raised to $269 from $265 at BofA

Becton Dickinson First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business

BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

Becton Dickinson (NYSE:BDX) Ticks All The Boxes When It Comes To Earnings Growth

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25

DEI Pay Incentives Come Under Pressure After Two-Year Surge

BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development

Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care

Becton, Dickinson and Company's (NYSE:BDX) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

BD to Announce Financial Results for its First Quarter of Fiscal 2025

New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer